Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview
10592studies shown
Showing 6,553-6,564 of 10,592
Drug study icon
CompletedNCT05796791

Ketamine and Motivational Enhancement Therapy for Addiction

This summary needs review. Please check the official study record and contact the research team for details.

In United States
AddictionDrugA study involving a medication or substance.From 21 Years to 65 Years
Countries
United States
Sponsor
Medical University of South Carolina
Condition
Addiction
Drug study icon
CompletedNCT03960658

Ketamine and Prolonged Exposure in PTSD

This summary needs review. Please check the official study record and contact the research team for details.

In United States
PTSDDrugFrom 18 Years to 75 Years
Countries
United States
Sponsor
Minneapolis Veterans Affairs Medical Center
Condition
PTSD
Drug study icon
CompletedNCT00749203

Ketamine as a Rapid Treatment for PTSD (PTSD)

This summary needs review. Please check the official study record and contact the research team for details.

In United States
PTSD, Depression, ...DrugFrom 21 Years to 55 Years
Countries
United States
Sponsor
Dennis Charney
Condition
PTSD, Depression, ...
Drug study icon
CompletedNCT02397889

Ketamine as a Treatment for PTSD (PTSD)

This summary needs review. Please check the official study record and contact the research team for details.

In United States
PTSDDrugFrom 18 Years to 65 Years
Countries
United States
Sponsor
Icahn School of Medicine at Mount Sinai
Condition
PTSD
Drug study icon
CompletedNCT01881763

Ketamine as an Augmentation Strategy for Electroconvulsive Therapy (ECT) in Depression

This study exists to compare options and see whether a therapy or guided support program offers something meaningfully different. Researchers are trying to understand whether a therapy or guided support program can improve attention, thinking, or day-to-day functioning.

In United States
Depression, BipolarityDrugFrom 18 Years to 70 Years
Countries
United States
Sponsor
Northwell Health
Condition
Depression, Bipolarity
Drug study icon
Active Not RecruitingNCT03573349

Ketamine Associated ACC GABA and Glutamate Change and Depression Remission:

This study is looking at whether Ketamine can help people with depression, Treatment Resistant Depression, or Depression in bipolarity. Participants take part in Ketamine and complete follow-up assessments.

In United States
Depression, BipolarityDrugFrom 18 Years to 65 Years
Countries
United States
Sponsor
Mayo Clinic
Condition
Depression, Bipolarity
Drug study icon
Enrolling By InvitationNCT06736769

Ketamine Effects on Learning In Eating disorders

This summary needs review. Please check the official study record and contact the research team for details.

In United States
Eating disordersDrugFrom 16 Years to 26 Years
Countries
United States
Sponsor
Amanda Downey, MD
Condition
Eating disorders
Drug study icon
CompletedNCT02094898

Ketamine for Depression and Suicide prevention

This summary needs review. Please check the official study record and contact the research team for details.

In United States
Depression, SuicidalityDrugFrom 18 Years to 65 Years
Countries
United States
Sponsor
Mayo Clinic
Condition
Depression, Suicidality
Drug study icon
TerminatedNCT05051449

Ketamine for OUD and Comorbid Depression (OUDCD)

This summary needs review. Please check the official study record and contact the research team for details.

In United States
Depression, AddictionDrugFrom 18 Years to 65 Years
Countries
United States
Sponsor
University of Maryland, Baltimore
Condition
Depression, Addiction
Drug study icon
TerminatedNCT06111339

Ketamine for OUD and Suicide prevention in the ED

This summary needs review. Please check the official study record and contact the research team for details.

In United States
Suicidality, AddictionDrugOver 18 Years
Countries
United States
Sponsor
Brigham and Women's Hospital
Condition
Suicidality, Addiction
Drug study icon
CompletedNCT01507181

Ketamine For Suicide prevention

This summary needs review. Please check the official study record and contact the research team for details.

In United States
SuicidalityDrugFrom 18 Years to 80 Years
Countries
United States
Sponsor
James Murrough
Condition
Suicidality
Drug study icon
CompletedNCT01944293

Ketamine for Suicide prevention in Depression in bipolarity

This study exists to compare options and see whether questionnaires and follow-up reports offers something meaningfully different. Researchers are trying to understand what questionnaires and follow-up reports could change in day-to-day care and decision-making.

In United States
Bipolarity, Depression, ...DrugFrom 18 Years to 65 Years
Countries
United States
Sponsor
New York State Psychiatric Institute
Condition
Bipolarity, Depression, ...
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.